Healthcare & Biotech

Chicago – September 15, 2026 -- The American Board of Medical Specialties (ABMS) will gather more than 400 healthcare professionals at the Loews O'Hare Hotel in Rosemont, Illinois, from September 16-18 for its annual conference on physician board certification.

Conference agenda spans 40 breakout sessions and AI-focused workforce debates

The three-day program includes two plenary sessions, 40 breakout sessions, one Sponsor Spotlight, four Exhibitor Showcases, and a 40-poster session. Core topics cover artificial intelligence in medicine, professionalism standards, innovation assessment methods, competency-based medical education, and structural shifts in the US physician workforce.

Baltimore – September 15, 2026 -- Sixty percent of health plans collect social drivers of health (SDoH) screening data, yet just 7% describe their organizations as "very effective" at converting that data into action, according to new research from Sage Growth Partners.

The consultancy surveyed 50 health plan leaders for a report titled "From SDoH Data to Maternal Health Action," the third and final installment in its State of Maternal & NICU Care 2026 series. Eighty percent of respondents said they are only "somewhat confident" in their ability to use the SDoH data they already hold.

Valencia, Calif. – September 15, 2026 -- Bioness Medical, Inc. and OneStep have struck a partnership that lets clinicians measure patient gait and mobility using only a smartphone, both in clinic and in daily life, the companies announced.

Data from 300 patients shows measurable gains in walking speed and stride length

More than 300 patients were evaluated on OneStep's gait analysis platform to gauge the immediate impact of functional electrical stimulation from Bioness' L300 Go and L300 Go Plus systems. Among adults using the L300 Go Plus, stride length increased by 5.9 cm and walking velocity rose from 0.68 to 0.74 m/s, with parallel gains in overall and symmetry-based gait scores.

Austin, Texas – September 15, 2026 -- Milagro has extended its autonomous surgical coding platform to three additional ambulatory surgery centers operated by Constitution Surgery Alliance (CSA), bringing total deployment to 12 CSA facilities across New England and the Northeast.

CSA scales automated coding while keeping certified coders in the review loop

The expansion supports increasingly complex surgical coding workflows at CSA, one of the largest independent operators of outpatient surgery centers in the U.S. Sayword Hill, SVP of Revenue Cycle for CSA, said Milagro's automation is layered with the organization's existing coding review, quality assurance and auditing processes, allowing certified coding professionals to maintain oversight as automation scope grows.

Delray Beach, Fla. – – September 15, 2026 -- The global High Flow Nasal Cannula (HFNC) market is projected to grow from USD 0.94 billion in 2026 to USD 1.44 billion by 2031, a compound annual growth rate of 8.9%, according to MarketsandMarkets.

North America leads a market shifting toward recurring consumables revenue

North America held the largest regional share of the HFNC market in 2025, supported by advanced critical-care infrastructure and established manufacturers. By product, consumables and accessories outpaced systems in market share, while adults represented the largest patient-type segment. Acute respiratory failure treatment led application demand, and hospitals remained the dominant end-user category due to intensive care unit and emergency department volumes.

Fremont, Calif. – September 15, 2026 -- Q'Apel Medical has launched the Lynx Aspiration Catheter System in the United States, expanding its neurovascular portfolio into the aspiration category for mechanical thrombectomy, the standard of care for acute ischemic stroke caused by vessel occlusion.

Lynx becomes the second Q'Apel product built on proprietary QLCT technology

The Lynx system marks the second device to feature Q'Apel's proprietary Q'Apel Laser Cut Tube (QLCT) technology, following the company's earlier product on this engineering platform. The catheters use a bimetal shaft design with an open-spaced nitinol structure intended to balance proximal support with distal flexibility while resisting kinking during navigation through complex cerebrovascular anatomy.

Quebec City – September 15, 2026 -- Icentia has appointed Sanjay Voleti as President and CEO, tasking the digital health veteran with accelerating the cardiac diagnostics company's commercial expansion in the United States.

Voleti succeeds co-founder Pierre Paquet after the company built operations across four countries

Voleti replaces co-founder Pierre Paquet, who led Icentia from its founding as a Canadian health-tech startup into an international operator with a presence in Canada, the United Kingdom, Ireland and the United States. Paquet said the company's CardioSTAT platform has become a reference point in continuous ambulatory ECG recording and that the time had come to bring in a leader experienced in scaling technology companies internationally.

New York – September 15, 2026 -- AEYE Health published peer-reviewed results in Frontiers in Digital Health confirming its FDA-cleared AEYE-DS system achieved over 99% imageability across three prospective, controlled pivotal trials involving more than 1,200 diabetic patients.

Trial data validate the clinical foundation behind AEYE-DS's two FDA clearances

The study, covering trials AEYE-1, AEYE-2 and AEYE-3, benchmarked the autonomous AI against reading center multi-expert clinical review. AEYE-DS requires only a single image per eye, works with both portable handheld and tabletop cameras, and rarely requires pupil dilation -- making it the only FDA-cleared portable autonomous solution for diabetic retinopathy on the market, according to the company.

New York – September 13, 2026 -- BRG has appointed Jamie LaGuardia-Frie as managing director in its Healthcare practice, tasking her with leading business development and client strategy for the firm's Healthcare Advisory team.

LaGuardia-Frie brings more than 20 years of healthcare consulting and technology experience

Based in New York, she joins after serving as managing director and chief commercial officer for Alvarez & Marsal's Health Industry Group. She spent nearly a decade at Guidehouse, holding roles including Health Growth Leader and East Regional Market Leader for Commercial Healthcare. Earlier in her career, she worked in consulting, business development and technology at Accretive Health and Allscripts.

Louisville, Ky. – September 13, 2026 -- Induction Therapies and Collagen P.I.N., in partnership with aesthetic physician Dr. Shino Bay Aguilera, released new clinical findings on a treatment protocol combining Collagen P.I.N. microneedling with PRX8, a plant-derived exosome serum, for melasma in a patient with Fitzpatrick skin type V.

Patient shows sustained improvement after four treatments over eight weeks

The case involved a woman with longstanding facial melasma who had previously used topical hydroquinone and tranexamic acid without full resolution. She underwent four Collagen P.I.N. treatments over an eight-week period, with TRUExosomes PRX8 Plant-Exo Stimulation Serum applied after each session and daily sunscreen maintained throughout.

Visible improvement in the appearance of melasma was observed across the treatment course and persisted at the two-week follow-up after the final treatment, with no adverse reactions reported.